BAVA Bavarian Nordic A/S

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

COPENHAGEN, Denmark, November 5, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4.92% of the shares and voting rights in Bavarian Nordic A/S as of October 30, 2025.

About Bavarian Nordic

Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit .

Contact investors:

Europe: Disa Tuominen, IR Manager,

US: Graham Morrell, Gilmartin Group, , Tel:

Contact media:

Nicole Seroff, Vice President Corporate Communications, , Tel:

Company Announcement no. 39 / 2025

Attachment



EN
05/11/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Bavarian Nordic A/S

 PRESS RELEASE

Bavarian Nordic iværksætter nyt langsigtet incitamentsprogram for konc...

Bavarian Nordic iværksætter nyt langsigtet incitamentsprogram for koncernledelsen og udvalgte medarbejdere KØBENHAVN, Danmark, 18. december 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at bestyrelsen har besluttet at etablere et nyt langsigtet incitamentsprogram for koncernledelsen som en del af den årlige aflønning i overensstemmelse med vederlagspolitikken, som er vedtaget på generalforsamlingen. Medlemmer af koncernledelsen tildeles performancebaserede betingede aktier, der er baseret på succesfuld opnåelse af relevante Key Performance Indicators (KPI’er), målt over en treårig...

 PRESS RELEASE

Bavarian Nordic Establishes Long-term Incentive Program for Members of...

Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees COPENHAGEN, Denmark, December 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management as part of the annual remuneration as laid out in the Remuneration Policy, adopted at the annual general meeting. Members of the Executive Management are granted performance restricted stock units (Performance RSUs), subject to the successful achievement of relevant Key Performance In...

 PRESS RELEASE

Bavarian Nordic vil foretage aktietilbagekøb for op til DKK 500 mio.

Bavarian Nordic vil foretage aktietilbagekøb for op til DKK 500 mio. KØBENHAVN, Danmark, 2. december 2025 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag sin hensigt om at iværksætte et engangsprogram for tilbagekøb af egne aktier for op til DKK 500 mio., som skal gennemføres over de næste 12 måneder. Denne beslutning skal ses i lyset af en nuværende stærk likviditetsposition, som følge af det nylige salg af Priority Review Voucher og en fortsat positiv pengestrøm fra driften. Pr. 30. september 2025 udgjorde værdipapirer, kontanter og likvide midler DKK 2.978 mio., hvoraf cirka DKK 800 mi...

 PRESS RELEASE

Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Mill...

Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million COPENHAGEN, Denmark, December 2, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12 months. This decision should be viewed in the context of a current strong cash position, resulting from the recent sale of the Priority Review Voucher and a continued positive cash flow from operations. As of September 30, 2025, securities, cash and cash equivalents were DKK 2,978 million, of which approximately DKK 800 ...

 PRESS RELEASE

Bavarian Nordic offentliggør delårsregnskab for de første ni måneder a...

Bavarian Nordic offentliggør delårsregnskab for de første ni måneder af 2025 KØBENHAVN, Danmark, 14. november 2025 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag regnskab for de første ni måneder af 2025 samt rapporterede på begivenheder for tredje kvartal 2025. Omsætningen i de første ni måneder steg med 32% til DKK 4.793 mio., hvilket afspejler en stærk udvikling i både Travel Health og Public Preparedness. Travel Health omsætning steg med 23% til DKK 2.327 mio. sammenlignet med de første ni måneder af 2024, hvilket primært var drevet af øget efterspørgsel på vacciner mod rabie...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch